cyclin-dependent protein kinase inhibitors (ManRos Therapeutics)

N/A

Report date: 2025/03/19 11:37:52
NME

Base Information

Drug Namecyclin-dependent protein kinase inhibitors (ManRos Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase inhibitors
TargetsCyclin-dependent kinase
Therapy Area/IndicationsPolycystic Kidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesManros Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesManros Therapeutics
Inactive CompaniesN/A
Active IndicationsPolycystic Kidney Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A